🌿 Cannabis Drug Interaction CYP450 Simulator

Baseline CYP450 Drug Metabolism

Placeholder: liver enzymes clear the drug at a steady, predictable rate.

• ~57: Liver CYP450 enzymes (placeholder gene family count)
• ~50%: Drugs metabolized via CYP3A4 (placeholder share of market drugs)
• 8–24h: Typical half-life (placeholder, drug dependent)
• 1.0×: Baseline blood level (placeholder therapeutic midpoint)

What CYP450 enzymes do

Placeholder: enzymes oxidize drug molecules so the body can excrete them efficiently.

Why steady clearance matters

Placeholder: constant clearance keeps blood levels inside the safe therapeutic window.

Cannabinoids Bind and Block the Enzyme

Placeholder: CBD competitively inhibits CYP3A4, CYP2C9, and CYP2C19.

• 3 enzymes: CBD inhibits (placeholder CYP3A4/2C9/2C19)
• Hours: Inhibition onset (placeholder after dosing)
• Yes: Dose-dependent effect (placeholder higher dose = more block)
• Competitive: Mechanism (placeholder active-site binding)

Competitive inhibition basics

Placeholder: cannabinoid molecules occupy the enzyme active site, blocking substrate.

Which enzymes are affected

Placeholder: CYP3A4, CYP2C9, CYP2C19 are the most cannabinoid-sensitive pathways.

Medication Metabolism Slows Down

Placeholder: with the enzyme blocked, drug clearance rate drops sharply.

• Up to 50%+: Clearance reduction (placeholder at high CBD dose)
• Extended: Half-life (placeholder, roughly doubles)
• Same day: Onset of slowdown (placeholder co-administration)
• Reversible: Reversibility (placeholder once CBD clears)

Clearance rate vs. dose

Placeholder: higher CBD dose produces proportionally slower drug clearance.

Backing up in the bloodstream

Placeholder: unmetabolized drug molecules accumulate faster than they are removed.

Drug Concentration Climbs Above Range

Placeholder: blood level rises past the therapeutic band as clearance lags.

• 1.3–2×: Level increase (placeholder typical elevation)
• 0.8–1.2×: Therapeutic band (placeholder normal range)
• Days: Time to peak (placeholder steady-state shift)
• Recommended: Monitoring (placeholder blood level checks)

Crossing the therapeutic band

Placeholder: level rise pushes concentration outside the safe target range.

Narrow vs wide index drugs

Placeholder: narrow-index drugs tolerate far less deviation before harm.

Outcome — Elevated Toxicity Risk

Placeholder: excess drug level raises risk of adverse effects or toxicity.

• Warfarin: Example narrow-index drugs (placeholder, anti-epileptics)
• High: Risk at high dose+narrow (placeholder combined scenario)
• Low: Risk at low dose+wide (placeholder combined scenario)
• Consult MD: Clinical guidance (placeholder before combining)

Why narrow-index drugs matter most

Placeholder: small level changes cause large safety margin shifts for these drugs.

Managing the interaction

Placeholder: dose adjustment or level monitoring can reduce toxicity risk.

Placeholder key insight: always check CYP450 interactions before combining cannabis with prescriptions.